Immunogenicity and Immunologic Memory after Hepatitis B Virus Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

Παρόμοια τεκμήρια

• Immunogenicity, Immunologic Memory, and Safety Following Measles Revaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy
  ανά: Abzug, Mark J., κ.ά.
  Έκδοση: (2012)
• Antibody Persistence and Immunologic Memory after Sequential Pneumococcal Conjugate and Polysaccharide Vaccination in HIV-Infected Children on Highly Active Antiretroviral Therapy
  ανά: Abzug, Mark J., κ.ά.
  Έκδοση: (2013)
• Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine
  ανά: Weinberg, Adriana, κ.ά.
  Έκδοση: (2015)
• Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment
  ανά: Weinberg, Adriana, κ.ά.
  Έκδοση: (2009)
• Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth
  ανά: Warshaw, Meredith G, κ.ά.
  Έκδοση: (2017)